Abstract
The aim of this study was to analyse the effect of LMB-89 protocol and surgical procedure at initial laparotomy on the outcome in children with abdominal B-cell NHL. The initial surgery intervention was: complete resection (20% pts), subtotal resection (20%), partial resection (4%), biopsy (36%). Postoperative complications occurred in 5 children. Complete recovery (CR) was achieved in 92% pts. There were 4% non responder patients. Two patients died before CR evaluation (tumour lysis syndrome; bleeding and multi organ failure after initial surgery). One patient died in CCR from sepsis probably influenced by the previous local operation. 10.8% patients relapsed. The estimate EFS for all patients with AB-NHL is 81%, 85% for stage III and 73% for stage IV. Major surgery in advanced stages is not recommended since it delays chemotherapy and fails to improve overall survival.
MeSH terms
-
Abdominal Neoplasms / drug therapy
-
Abdominal Neoplasms / pathology
-
Abdominal Neoplasms / surgery*
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Chemotherapy, Adjuvant
-
Child
-
Child, Preschool
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Disease-Free Survival
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Female
-
Humans
-
Hydrocortisone / administration & dosage
-
Infant
-
Laparotomy
-
Leucovorin / administration & dosage
-
Lymphoma, B-Cell / drug therapy
-
Lymphoma, B-Cell / pathology
-
Lymphoma, B-Cell / surgery*
-
Male
-
Methotrexate / administration & dosage
-
Prednisone / administration & dosage
-
Risk Factors
-
Time Factors
-
Treatment Outcome
-
Vincristine / administration & dosage
Substances
-
Cytarabine
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Leucovorin
-
Prednisone
-
Hydrocortisone
-
Methotrexate